Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes

@article{Diego2015AxillarySA,
  title={Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes},
  author={Emilia J. Diego and PhD Priscilla F. McAuliffe and MPH FNCBC FACS Atilla Soran and Kandace P McGuire and Ronald R. Johnson and M. Bonaventura and Gretchen M. Ahrendt},
  journal={Annals of Surgical Oncology},
  year={2015},
  volume={23},
  pages={1549-1553}
}
Neoadjuvant chemotherapy (NAC) downstages axillary disease in 55 % of node-positive (N1) breast cancer. The feasibility and accuracy of sentinel lymph node biopsy (SLNB) after NAC for percutaneous biopsy-proven N1 patients who are clinically node negative (cN0) by physical examination after NAC is under investigation. ACOSOG Z1071 reported a false-negative rate of <10 % if ≥3 nodes are removed with dual tracer, including excision of the biopsy-proven positive lymph node (BxLN). We report our… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Targeted axillary dissection improves axillary evaluation following neoadjuvant chemotherapy in node positive breast cancer

  • AS Caudle, WT Yang, EA Mittendorf
  • Paper presented at: 68th SSO Annual Cancer…
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…